Bi-allelic loss of ERGIC1 causes relatively mild arthrogryposis.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
09 2021
Historique:
revised: 18 05 2021
received: 31 03 2021
accepted: 19 05 2021
pubmed: 27 5 2021
medline: 27 1 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

Arthrogryposis describes the presence of multiple joint-contractures. Clinical severity of this phenotype is variable, and more than 400 causative genes have been proposed. Among these, ERGIC1 is a recently reported candidate encoding a putative transmembrane protein of the ER-Golgi interface. Two homozygous missense variants have been reported in patients with relatively mild non-syndromic arthrogryposis. In a consanguineous family with two affected siblings presenting congenital arthrogryposis and some facial dysmorphism we performed prenatal array-CGH, postnatal targeted exome and genome sequencing. Genome sequencing identified a homozygous 22.6 Kb deletion encompassing the promoter and first exon of ERGIC1. mRNA quantification showed the complete absence of ERGIC1 expression in the two affected siblings and a decrease in heterozygous parents. Our observations validate the pathogenic role of ERGIC1 in congenital arthrogryposis and demonstrate that complete loss of function causes a relatively mild phenotype. These findings will contribute to improve genetic counseling of ERGIC1 mutations.

Identifiants

pubmed: 34037256
doi: 10.1111/cge.14004
pmc: PMC8453841
doi:

Substances chimiques

ERGIC1 protein, human 0
RNA, Messenger 0
Vesicular Transport Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-333

Subventions

Organisme : Fondation Privée des HUG
ID : QS05-28

Informations de copyright

© 2021 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Am J Med Genet C Semin Med Genet. 2019 Sep;181(3):310-326
pubmed: 31369690
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Genet. 2018 Jan;93(1):160-163
pubmed: 28317099
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Genome Res. 2011 Jun;21(6):974-84
pubmed: 21324876
Bioinformatics. 2018 Oct 15;34(20):3572-3574
pubmed: 29669011
Am J Hum Genet. 2012 Oct 5;91(4):597-607
pubmed: 23040492
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
Am J Hum Genet. 2019 Jul 3;105(1):132-150
pubmed: 31230720
BMC Med Genet. 2020 May 18;21(1):109
pubmed: 32423379
Genome Res. 2012 Aug;22(8):1525-32
pubmed: 22585873
Pediatrics. 1970 Dec;46(6):891-9
pubmed: 5491443
Clin Genet. 2021 Sep;100(3):329-333
pubmed: 34037256
J Biol Chem. 2004 Nov 5;279(45):47242-53
pubmed: 15308636

Auteurs

Caterina Marconi (C)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Laure Lemmens (L)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Frédéric Masclaux (F)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Francesca Mattioli (F)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Joël Fluss (J)

Pediatric Specialties division, Department of Women, Children and Adolescents, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Philippe Extermann (P)

Prenatal Ultrasonography, Dianecho, Genève (CH), Switzerland.

Purificacion Mendez (P)

Obstetrics and Gynecology, Centre Médical Eaux-Vives, Genève (CH), Switzerland.

Russia Ha-Vinh Leuchter (RH)

Pediatric Specialties division, Department of Women, Children and Adolescents, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Elissavet Stathaki (E)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Sacha Laurent (S)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Eva Hammar (E)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Anne Vannier (A)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Konstantinos Varvagiannis (K)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.

Michel Guipponi (M)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Genève (CH), Switzerland.

Frédérique Sloan-Bena (F)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Genève (CH), Switzerland.

Jean-Louis Blouin (JL)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Genève (CH), Switzerland.

Marc Abramowicz (M)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Genève (CH), Switzerland.

Siv Fokstuen (S)

Genetic Medicine division, Diagnostic Department, Hôpitaux Universitaires de Genève, Genève (CH), Switzerland.
Department of Genetic Medicine and Development, School of Medicine, University of Geneva, Genève (CH), Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH